Work

Cost-comparison analysis of bendamustine, rituximab, etoposide and carboplatin (TREC) vs. RICE/R-DHAP in relapsed lymphoma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e19517

Authors: Anneliese M Bodding-Long, L. Elizabeth Budde, Jennifer E Roden, Ajay K. Gopal, Tara L Chen

Institutions: University of Washington, City Of Hope National Medical Center, Seattle Cancer Care Alliance, Fred Hutch Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2460884575

Cites:

Cited by: 2

Related to: 10